Southern Arizona | We've Got You Covered

Johnson & Johnson, Risperdal maker hit with $8B verdict

PHILADELPHIA (AP) — A Philadelphia jury has decided that Johnson & Johnson and Janssen Pharmaceuticals should pay $8 billion over an antipsychotic drug that the plaintiff’s attorneys say is linked to the growth of female breast tissue in boys.

A law firm for the plaintiff released a statement Tuesday saying the companies used an organized scheme to make billions of dollars while illegally marketing and promoting the drug called Risperdal.

Johnson & Johnson says the jury’s award “is grossly disproportionate with the initial compensatory award in this case,” and that the company is “confident it will be overturned.”

Associated Press

Associated Press

Scroll to top
Skip to content